Literature DB >> 31433537

Risk of comorbid cardiovascular disease in Korean long-term cancer survivors.

Jinyoung Shin1, Hyeonyoung Ko2, Yoon-Ho Choi3, Inyoung Choi4, Yun-Mi Song4.   

Abstract

BACKGROUND: Cardiovascular disease (CVD) is a common cause of death in cancer survivors. We evaluated the risk of comorbid CVD in long-term cancer survivors according to specific cancer site.
METHODS: Study subjects included 47,171 Koreans aged over 40 years who visited a health promotion centre between 2010 and 2012. Information on CVD and cancer was obtained from self-report. Comorbid CVD was defined as stroke, myocardial infarction or angina pectoris. The risk of comorbid CVD in survivors was compared with that in non-cancer subjects using multiple logistic regression analysis.
RESULTS: Among cancer survivors (n = 3,753), 330 events of CVD were reported. Age- and sex-adjusted analysis showed that odds ratio (OR) for comorbid CVD in survivors was 1.52 (95% confidence interval: 1.34-1.72) compared to non-cancer subjects (n = 43,418). After adjusting for health-related behaviour and medical history, only lung cancer survivors had 2.44 (1.01-5.89)-fold higher OR for CVD. In stratified analysis, significantly higher OR for CVD was evident in lung cancer survivors with hypertension who did not perform regular physical exercise.
CONCLUSIONS: Adult cancer survivors may have an increased risk of comorbid CVD that might be mediated in part by known cardiovascular risk factors depending on the specific cancer site.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  cardiovascular diseases; health behaviour; lung neoplasms; neoplasms; survivors

Mesh:

Year:  2019        PMID: 31433537     DOI: 10.1111/ecc.13151

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  1 in total

1.  Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment.

Authors:  Nika Guberina; Christoph Pöttgen; Martin Schuler; Maja Guberina; Georgios Stamatis; Till Plönes; Martin Metzenmacher; Dirk Theegarten; Thomas Gauler; Kaid Darwiche; Clemens Aigner; Wilfried E E Eberhardt; Martin Stuschke
Journal:  Radiat Oncol       Date:  2022-07-16       Impact factor: 4.309

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.